Related Experiment Video
Updated: Jun 10, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Treatment options for paediatric diabetes.
Alberto Verrotti1, Rosa Maria Chiuri, Annalisa Blasetti
1University of Chieti, Department of Pediatrics, Italy.
Expert Opinion on Pharmacotherapy
|July 30, 2010
Summary
Optimizing diabetes management in children is crucial due to its high incidence. Current treatments focus on insulin for type 1, while new strategies aim to preserve beta-cell function, offering hope for type 2 diabetes cures.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Diabetes Mellitus Management
Background:
- Diabetes mellitus is the most prevalent endocrine disorder in childhood.
- The global rise in diabetes incidence highlights significant health, social, and economic burdens.
- Effective disease management and prevention are paramount.
Purpose of the Study:
- To review current and emerging treatment options for pediatric type 1 and type 2 diabetes.
- To focus on insulin regimens and novel therapeutic approaches.
- To address the need for evidence-based treatments in children.
Main Methods:
- Comprehensive literature review of treatment strategies for pediatric diabetes.
- Analysis of insulin therapies for type 1 diabetes.
- Evaluation of alternative and emerging therapies, including cellular and immunomodulatory approaches.
Main Results:
- Insulin remains the cornerstone for type 1 diabetes treatment in children.
- New therapies aim to preserve residual beta-cell function and prevent complications.
- Limited data exist on the safety and efficacy of type 2 diabetes treatments in pediatric populations, with many adult oral agents unstudied in children.
Conclusions:
- Personalized therapy regimens are essential for optimal glycemic control in pediatric diabetes.
- Beta-cell replacement, preservation of function, and exploration of oral agents offer potential pathways to a cure.
- Further research is needed for effective and safe type 2 diabetes management in children.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...